Trials.boehringer-ingelheim.com

Countable Data Brief

Boehringer-ingelheim.com is tracked by us since April, 2011. Over the time it has been ranked as high as 67 953 in the world, while most of its traffic comes from India, where it reached as high as 19 791 position. Trials.boehringer-ingelheim.com receives less than 13.5% of its total traffic. It was owned by several entities, from boehringer ingelheim pharma gmbh & co. kg 3460-02-06 Corporate Department Trademarks to BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG, it was hosted by T-Systems Enterprise Services GmbH, Amazon Data Services Ireland Limited and others. While CSC CORPORATE DOMAINS INC. was its first registrar, now it is moved to NAMESHIELD SAS.

Trials.boehringer-ingelheim has a decent Google pagerank and bad results in terms of Yandex topical citation index. We found that Trials.boehringer-ingelheim.com is poorly ‘socialized’ in respect to any social network. According to MyWot and Google safe browsing analytics, Trials.boehringer-ingelheim.com is quite a safe domain with no visitor reviews.

Traffic Analysis

It seems that the number of visitors and pageviews on this site is too low to be displayed, sorry.

SEO Stats

Trials.boehringer-ingelheim.com has Google PR 4.

Social Engagement

Trials.boehringer-ingelheim.com has 0% of its total traffic coming from social networks (in last 3 months) and the most active engagement is detected in Twitter (5 twitts)

Safety

Safety status of Trials.boehringer-ingelheim.com is described as follows: MyWOT reports its overall reputation as good and Google Safe Browsing reports its status as safe.